Abstract
AlphaGenome, recently announced in a preprint by Avsec et al., is Google DeepMind's powerful 'Swiss army knife' for predicting molecular effects from non-coding DNA. Remarkably, it does so with base-pair resolution while maintaining long-range context. Here, we discuss AlphaGenome's promise and limitations in prioritizing and functionally interpreting non-coding variants underlying human traits and diseases.